NO995809L - Farmasoeytisk formulering av omeprazol - Google Patents
Farmasoeytisk formulering av omeprazolInfo
- Publication number
- NO995809L NO995809L NO995809A NO995809A NO995809L NO 995809 L NO995809 L NO 995809L NO 995809 A NO995809 A NO 995809A NO 995809 A NO995809 A NO 995809A NO 995809 L NO995809 L NO 995809L
- Authority
- NO
- Norway
- Prior art keywords
- omeprazole
- pharmaceutical formulation
- formulation
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9702000A SE9702000D0 (sv) | 1997-05-28 | 1997-05-28 | New pharmaceutical formulation |
PCT/SE1998/000922 WO1998053803A1 (en) | 1997-05-28 | 1998-05-18 | Pharmaceutical formulation of omeprazole |
Publications (3)
Publication Number | Publication Date |
---|---|
NO995809D0 NO995809D0 (no) | 1999-11-26 |
NO995809L true NO995809L (no) | 2000-01-28 |
NO328100B1 NO328100B1 (no) | 2009-12-07 |
Family
ID=20407122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19995809A NO328100B1 (no) | 1997-05-28 | 1999-11-26 | Farmasoytisk formulering av omeprazol |
Country Status (41)
Country | Link |
---|---|
US (1) | US6090827A (no) |
EP (1) | EP0984773B1 (no) |
JP (1) | JP4649001B2 (no) |
KR (1) | KR100540721B1 (no) |
CN (1) | CN1123338C (no) |
AR (1) | AR012698A1 (no) |
AT (1) | ATE234078T1 (no) |
AU (1) | AU722879B2 (no) |
BR (1) | BR9809484A (no) |
CA (1) | CA2290531C (no) |
CZ (1) | CZ298972B6 (no) |
DE (1) | DE69812089T2 (no) |
DK (1) | DK0984773T3 (no) |
DZ (1) | DZ2494A1 (no) |
EE (1) | EE03903B1 (no) |
EG (1) | EG24044A (no) |
ES (1) | ES2195342T3 (no) |
HK (1) | HK1025744A1 (no) |
HR (1) | HRP980260B1 (no) |
HU (1) | HU229154B1 (no) |
ID (1) | ID24654A (no) |
IL (1) | IL132895A0 (no) |
IS (1) | IS2856B (no) |
MA (1) | MA26497A1 (no) |
MY (1) | MY122298A (no) |
NO (1) | NO328100B1 (no) |
NZ (1) | NZ500886A (no) |
PL (1) | PL194634B1 (no) |
PT (1) | PT984773E (no) |
RS (1) | RS49629B (no) |
RU (1) | RU2207121C2 (no) |
SA (1) | SA98190304B1 (no) |
SE (1) | SE9702000D0 (no) |
SI (1) | SI0984773T1 (no) |
SK (1) | SK286625B6 (no) |
TN (1) | TNSN98068A1 (no) |
TR (1) | TR199902890T2 (no) |
TW (1) | TW575435B (no) |
UA (1) | UA71541C2 (no) |
WO (1) | WO1998053803A1 (no) |
ZA (1) | ZA984178B (no) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6645988B2 (en) * | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US6699885B2 (en) * | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
US6096340A (en) | 1997-11-14 | 2000-08-01 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
US6174548B1 (en) * | 1998-08-28 | 2001-01-16 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
CA2298823C (en) * | 1998-04-20 | 2011-06-07 | Eisai Co., Ltd. | Stabilized composition comprising a benzimidazole type compound |
SE9803772D0 (sv) * | 1998-11-05 | 1998-11-05 | Astra Ab | Pharmaceutical formulation |
SE9902386D0 (sv) * | 1999-06-22 | 1999-06-22 | Astra Ab | New formulation |
US6245913B1 (en) | 1999-06-30 | 2001-06-12 | Wockhardt Europe Limited | Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole |
ES2168043B1 (es) | 1999-09-13 | 2003-04-01 | Esteve Labor Dr | Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido. |
JP4081273B2 (ja) | 1999-10-20 | 2008-04-23 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ベンズイミダゾール系化合物安定化方法 |
US20040092511A1 (en) * | 1999-12-10 | 2004-05-13 | Billstein Stephan Anthony | Pharmaceutical combinations and their use in treating gastrointestinal and abdominal viscera disorders |
US20020192299A1 (en) * | 2000-12-28 | 2002-12-19 | Rajneesh Taneja | Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination |
JP2002234842A (ja) * | 2001-02-09 | 2002-08-23 | Kyowa Yakuhin Kogyo Kk | 内服腸溶性製剤 |
US20040006111A1 (en) * | 2002-01-25 | 2004-01-08 | Kenneth Widder | Transmucosal delivery of proton pump inhibitors |
US20040082618A1 (en) * | 2002-07-03 | 2004-04-29 | Rajneesh Taneja | Liquid dosage forms of acid labile drugs |
FR2843121B3 (fr) | 2002-08-02 | 2004-09-10 | Rhodia Chimie Sa | Agent ignifugeant, procede de preparation et l'utilisation de cet agent |
US20070243251A1 (en) * | 2002-12-20 | 2007-10-18 | Rajneesh Taneja | Dosage Forms Containing A PPI, NSAID, and Buffer |
US20040121004A1 (en) * | 2002-12-20 | 2004-06-24 | Rajneesh Taneja | Dosage forms containing a PPI, NSAID, and buffer |
US20040146558A1 (en) * | 2003-01-28 | 2004-07-29 | Kyowa Pharmaceutical Co., Ltd. | Oral enteric-coated preparation |
CN1761465B (zh) * | 2003-01-29 | 2010-10-13 | 武田药品工业株式会社 | 制备被覆制剂的方法 |
PL377403A1 (pl) * | 2003-01-29 | 2006-02-06 | Takeda Pharmaceutical Company Limited | Sposób wytwarzania preparatu powlekanego |
JP4567340B2 (ja) * | 2003-01-29 | 2010-10-20 | 武田薬品工業株式会社 | 被覆製剤の製造方法 |
US20040248942A1 (en) * | 2003-02-20 | 2004-12-09 | Bonnie Hepburn | Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US20070292498A1 (en) * | 2003-11-05 | 2007-12-20 | Warren Hall | Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers |
CN1311824C (zh) * | 2004-04-21 | 2007-04-25 | 常州市第四制药厂有限公司 | 奥美拉唑肠溶微粒制剂及制备方法 |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8815916B2 (en) * | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
EP1747800B1 (en) * | 2005-07-29 | 2009-03-18 | Rottapharm S.p.A. | Combination of itriglumide and proton pump inhibitors in the treatment of gastrointestinal and related disorders |
CA2654402A1 (en) * | 2006-06-01 | 2007-12-06 | Adel Penhasi | Multiple unit pharmaceutical formulation |
KR101436516B1 (ko) * | 2007-07-23 | 2014-09-02 | 주식회사태평양제약 | 코팅된 펠렛을 함유하는 현탁정 및 이의 제조방법 |
CN101808622A (zh) * | 2007-09-28 | 2010-08-18 | 西梯茜生命工学股份有限公司 | 含有埃索美拉唑的药物组合物 |
CN101980701A (zh) * | 2008-03-28 | 2011-02-23 | 菲尔若国际公司 | 用于预防心血管疾病的胶囊 |
PL2334378T3 (pl) | 2008-08-19 | 2014-09-30 | Xenoport Inc | Proleki wodorofumaranu metylu, ich kompozycje farmaceutyczne i sposoby zastosowania |
AU2013305684B2 (en) | 2012-08-22 | 2016-11-24 | Xenoport, Inc. | Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof |
US10945984B2 (en) | 2012-08-22 | 2021-03-16 | Arbor Pharmaceuticals, Llc | Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects |
CN102961356A (zh) * | 2012-12-11 | 2013-03-13 | 山西云鹏制药有限公司 | 一种含奥美拉唑的蓝色肠溶片剂的制备方法 |
US10179118B2 (en) | 2013-03-24 | 2019-01-15 | Arbor Pharmaceuticals, Llc | Pharmaceutical compositions of dimethyl fumarate |
JP2016534133A (ja) | 2013-09-06 | 2016-11-04 | ゼノポート,インコーポレイティド | (n,n−ジエチルカルバモイル)メチル メチル(2e)ブト−2−エン−1,4−ジオエートの結晶形態、その合成方法及び使用 |
US20150079180A1 (en) * | 2013-09-18 | 2015-03-19 | Xenoport, Inc. | Nanoparticle compositions of dimethyl fumarate |
US9999672B2 (en) | 2014-03-24 | 2018-06-19 | Xenoport, Inc. | Pharmaceutical compositions of fumaric acid esters |
WO2016174664A1 (en) | 2015-04-29 | 2016-11-03 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
WO2021153525A1 (ja) | 2020-01-27 | 2021-08-05 | 東和薬品株式会社 | エソメプラゾール経口製剤およびその製造方法 |
KR102432084B1 (ko) | 2021-11-16 | 2022-08-12 | 알리코제약(주) | S-오메프라졸을 함유하는 안정성이 개선되고 소형화된 정제 |
WO2024075017A1 (en) | 2022-10-04 | 2024-04-11 | Zabirnyk Arsenii | Inhibition of aortic valve calcification |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
SE8301182D0 (sv) * | 1983-03-04 | 1983-03-04 | Haessle Ab | Novel compounds |
GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
JPH05255088A (ja) * | 1991-11-05 | 1993-10-05 | Yoshitomi Pharmaceut Ind Ltd | 抗潰瘍剤含有製剤 |
JP2669446B2 (ja) * | 1992-03-23 | 1997-10-27 | 信越化学工業株式会社 | 医薬品コーティング液用原料粉粒体 |
JPH0733659A (ja) * | 1992-07-17 | 1995-02-03 | Yoshitomi Pharmaceut Ind Ltd | 抗潰瘍剤含有製剤 |
SE9301830D0 (sv) * | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
SE9302396D0 (sv) * | 1993-07-09 | 1993-07-09 | Ab Astra | A novel compound form |
SE9302395D0 (sv) * | 1993-07-09 | 1993-07-09 | Ab Astra | New pharmaceutical formulation |
HUT75775A (en) * | 1994-07-08 | 1997-05-28 | Astra Ab | Medicament with multiple unit tablated dosage form containing omeprazole |
SE9500422D0 (sv) * | 1995-02-06 | 1995-02-06 | Astra Ab | New oral pharmaceutical dosage forms |
-
1997
- 1997-05-28 SE SE9702000A patent/SE9702000D0/xx unknown
-
1998
- 1998-05-14 HR HR980260A patent/HRP980260B1/xx not_active IP Right Cessation
- 1998-05-14 AR ARP980102246A patent/AR012698A1/es not_active Application Discontinuation
- 1998-05-15 TW TW87107541A patent/TW575435B/zh not_active IP Right Cessation
- 1998-05-15 MA MA25077A patent/MA26497A1/fr unknown
- 1998-05-18 JP JP50056299A patent/JP4649001B2/ja not_active Expired - Fee Related
- 1998-05-18 ZA ZA984178A patent/ZA984178B/xx unknown
- 1998-05-18 AT AT98924700T patent/ATE234078T1/de active
- 1998-05-18 EE EEP199900540A patent/EE03903B1/xx not_active IP Right Cessation
- 1998-05-18 PL PL98337237A patent/PL194634B1/pl unknown
- 1998-05-18 CZ CZ0420299A patent/CZ298972B6/cs not_active IP Right Cessation
- 1998-05-18 CA CA002290531A patent/CA2290531C/en not_active Expired - Lifetime
- 1998-05-18 DZ DZ980104A patent/DZ2494A1/xx active
- 1998-05-18 NZ NZ500886A patent/NZ500886A/en not_active IP Right Cessation
- 1998-05-18 ID IDW991448A patent/ID24654A/id unknown
- 1998-05-18 ES ES98924700T patent/ES2195342T3/es not_active Expired - Lifetime
- 1998-05-18 DE DE69812089T patent/DE69812089T2/de not_active Expired - Lifetime
- 1998-05-18 RS YUP-608/99A patent/RS49629B/sr unknown
- 1998-05-18 WO PCT/SE1998/000922 patent/WO1998053803A1/en active IP Right Grant
- 1998-05-18 CN CN98805564A patent/CN1123338C/zh not_active Expired - Fee Related
- 1998-05-18 IL IL13289598A patent/IL132895A0/xx not_active IP Right Cessation
- 1998-05-18 HU HU0002182A patent/HU229154B1/hu not_active IP Right Cessation
- 1998-05-18 AU AU76803/98A patent/AU722879B2/en not_active Ceased
- 1998-05-18 RU RU99126869/14A patent/RU2207121C2/ru not_active IP Right Cessation
- 1998-05-18 SI SI9830433T patent/SI0984773T1/xx unknown
- 1998-05-18 KR KR1019997011083A patent/KR100540721B1/ko not_active IP Right Cessation
- 1998-05-18 UA UA99116247A patent/UA71541C2/uk unknown
- 1998-05-18 EP EP98924700A patent/EP0984773B1/en not_active Expired - Lifetime
- 1998-05-18 US US09/077,717 patent/US6090827A/en not_active Expired - Lifetime
- 1998-05-18 SK SK1590-99A patent/SK286625B6/sk not_active IP Right Cessation
- 1998-05-18 BR BR9809484-0A patent/BR9809484A/pt not_active Application Discontinuation
- 1998-05-18 DK DK98924700T patent/DK0984773T3/da active
- 1998-05-18 PT PT98924700T patent/PT984773E/pt unknown
- 1998-05-18 TR TR1999/02890T patent/TR199902890T2/xx unknown
- 1998-05-21 TN TNTNSN98068A patent/TNSN98068A1/fr unknown
- 1998-05-25 EG EG56898A patent/EG24044A/xx active
- 1998-05-27 MY MYPI98002355A patent/MY122298A/en unknown
- 1998-07-19 SA SA98190304A patent/SA98190304B1/ar unknown
-
1999
- 1999-11-11 IS IS5245A patent/IS2856B/is unknown
- 1999-11-26 NO NO19995809A patent/NO328100B1/no not_active IP Right Cessation
-
2000
- 2000-08-10 HK HK00105002A patent/HK1025744A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO995809L (no) | Farmasoeytisk formulering av omeprazol | |
NO994757D0 (no) | FramgangsmÕte for oral administrasjon av proteiner | |
NO995852L (no) | Ny form av S-omeprazol | |
NO20002851D0 (no) | Blandinger for nasal administrasjon av medikamenter | |
NO20001962D0 (no) | Terapeutisk anvendelse av kinolinderivater | |
FI972292A0 (fi) | Administrering av diabetes | |
IS5070A (is) | Nýtt form S-handhverfu ómeprasóls og lyfjablöndursem innihalda það | |
DK0797991T3 (da) | Lægemiddelformulering med forhalet frigivelse | |
DE59910858D1 (de) | Pharmazeutische zubereitung von moxifloxacin | |
NO20000932D0 (no) | Farmasøytisk preparat for kombinasjon av piperidinoalkanol og dekongestant | |
BR9610396A (pt) | Formulação farmacêutica | |
NO995251D0 (no) | FremgangsmÕte for administrering av haloterapi | |
EE04154B1 (et) | Omeprasooli valmistamise meetod | |
NO20001717D0 (no) | Serotonin-inneholdende formulering for oral administrering og anvendelse av samme | |
ID30032A (id) | Formulasi farmasi | |
FI973230A0 (fi) | Uusi farmaseuttinen formulaatio | |
DE69832974D1 (de) | Gerät zur intrakardialen verabreichung von medikamenten | |
NO20003393D0 (no) | FremgangsmÕte for fremstilling av en farmasøytisk formulering | |
BR9606066A (pt) | Composto e formulação farmacêutica | |
BR9612652A (pt) | Forma de administração farmacêutica | |
SI1124539T1 (en) | Pharmaceutical formulation comprising omeprazole | |
SE9600141D0 (sv) | Pharmaceutical formulation | |
SE9803952D0 (sv) | Pharmaceutical formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |